News
Interleukin (IL)-1 is a prototypic proinflammatory cytokine. It is produced by numerous cell types (i.e., macrophages, synoviocytes, endothelial cells, chondrocytes, osteoclasts) and is found in ...
The first direct and selective interleukin-1 (IL-1) receptor antagonist, anakinra can be used alone or in combination with any of the other DMARDs, except those in the tumor necrosis factor (TNF ...
All of us produce a growth factor—called IL-15—which effectively protects us from cancers. Its role is to boost the ...
genes were first cloned and characterized as the sixth IL-1 receptor (IL-1R1). Three receptor activating cytokines (IL-36α, IL-36β, IL-36γ) and one antagonist (IL-36Ra) were identified in quick ...
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...
Hosted on MSN1mon
Novel IL-7 Receptor Antagonist Shows Promise in Ulcerative ColitisSAN DIEGO -- Patients with moderate to severe ulcerative colitis experienced clinical, endoscopic, histological, and biological improvements with the first-in-class interleukin (IL)-7 receptor ...
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 and June 3 was host to the Poster Session: Genitourinary Cancer - Prostate, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results